CCL2 and ovarian cancer: In addition to affecting differentiation, TME-derived chemokines can recruit MDSCs to infiltrate into the tumor microenvironment, such as CCL2, CCL5, and other chemokines secreted by breast, gastric, and ovarian cancers [39].